Skip to main content

Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer.

Publication ,  Journal Article
Kane, RD; Paulson, DF
Published in: Natl Cancer Inst Monogr
December 1978

CEA level has been measured in a series of prostate cancer patients. Data are presented to show CEA correlation with clinical course and acid phosphatase level.

Duke Scholars

Published In

Natl Cancer Inst Monogr

ISSN

0083-1921

Publication Date

December 1978

Issue

49

Start / End Page

231

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Male
  • Humans
  • Diagnostic Errors
  • Carcinoembryonic Antigen
  • Acid Phosphatase
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kane, R. D., & Paulson, D. F. (1978). Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer. Natl Cancer Inst Monogr, (49), 231.
Kane, R. D., and D. F. Paulson. “Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer.Natl Cancer Inst Monogr, no. 49 (December 1978): 231.
Kane RD, Paulson DF. Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer. Natl Cancer Inst Monogr. 1978 Dec;(49):231.
Kane, R. D., and D. F. Paulson. “Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer.Natl Cancer Inst Monogr, no. 49, Dec. 1978, p. 231.
Kane RD, Paulson DF. Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer. Natl Cancer Inst Monogr. 1978 Dec;(49):231.

Published In

Natl Cancer Inst Monogr

ISSN

0083-1921

Publication Date

December 1978

Issue

49

Start / End Page

231

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Male
  • Humans
  • Diagnostic Errors
  • Carcinoembryonic Antigen
  • Acid Phosphatase